SEC Form 4 · accession 0001179110-17-006719
BeOne Medicines Ltd. · ONC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Xiaodong Wang
Director
Period of report
May 3, 2017
Accepted (ET)
May 5, 2017 · 5:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001651308
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| American Depositary SharesF1,F3 | May 3, 2017 | S | 9,970 | $40.7092 | D | 65,030 | D | |
| American Depositary SharesF1,F4 | May 4, 2017 | S | 4,491 | $41.009 | D | 60,539 | D | |
| Ordinary Shares | holding | — | — | — | 12,525,393 | D | ||
| Ordinary SharesF5 | holding | — | — | — | 214,531 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Each American Depositary Share represents 13 Ordinary Shares.
- F2The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.3550 to $41.1500, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price within the ranges set forth in footnotes (3) to (4).
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.36 to $41.23, inclusive.
- F5These securities are held in a UTMA account for Reporting Person's minor child, for which Reporting Person disclaims beneficial ownership.